Eli Lilly and Company
Anti-N3pGlu amyloid beta peptide antibodies and uses thereof

Abstract:

Antibodies to human N3pGlu A.beta., compositions comprising such N3pGlu A.beta. antibodies, and methods of using such N3pGlu A.beta. antibodies for the treatment of a disease characterized by deposition of A.beta. including clinical or pre-clinical Alzheimer's disease, Down's syndrome, and clinical or pre-clinical cerebral amyloid angiopathy.